Serum autoantibodies for the diagnosis and management of autoimmune liver diseases

Maria Is Achenza, Francesca Meda, Enrico Brunetta, Carlo Selmi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The spectrum of autoimmune liver diseases (AILD) includes primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis. The immunological mechanisms triggering the initiation and perpetuation of AILD remains unknown, while autoantigens are now recognized in most cases, and are generally nontraditional in their widespread distribution. Sensitive and specific methods for the detection of serum autoantibodies in patients affected by AILD represent a challenge for researchers and clinicians who desire to obtain an early and certain diagnosis as well as markers of disease control. To this regard, the use and interpretation of serum autoantibodies in AILD may be seen as paradigmatic for the large gaps in our knowledge based on the lack of true population-based studies. The present review article will critically discuss the available evidence on the use of autoantibody findings in the diagnosis or management of autoimmune liver disease.

Original languageEnglish (US)
Pages (from-to)717-729
Number of pages13
JournalExpert Review of Gastroenterology and Hepatology
Volume6
Issue number6
DOIs
StatePublished - Dec 2012
Externally publishedYes

Fingerprint

Autoantibodies
Autoimmune Diseases
Liver Diseases
Serum
Autoimmune Hepatitis
Sclerosing Cholangitis
Biliary Liver Cirrhosis
Autoantigens
Early Diagnosis
Research Personnel
Population

Keywords

  • autoimmune hepatitis
  • diagnosis
  • pathogenesis
  • primary biliary cirrhosis
  • primary sclerosing cholangitis

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Serum autoantibodies for the diagnosis and management of autoimmune liver diseases. / Achenza, Maria Is; Meda, Francesca; Brunetta, Enrico; Selmi, Carlo.

In: Expert Review of Gastroenterology and Hepatology, Vol. 6, No. 6, 12.2012, p. 717-729.

Research output: Contribution to journalArticle

Achenza, Maria Is ; Meda, Francesca ; Brunetta, Enrico ; Selmi, Carlo. / Serum autoantibodies for the diagnosis and management of autoimmune liver diseases. In: Expert Review of Gastroenterology and Hepatology. 2012 ; Vol. 6, No. 6. pp. 717-729.
@article{f01d49e538b64dd9b81420dce6d1d2ed,
title = "Serum autoantibodies for the diagnosis and management of autoimmune liver diseases",
abstract = "The spectrum of autoimmune liver diseases (AILD) includes primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis. The immunological mechanisms triggering the initiation and perpetuation of AILD remains unknown, while autoantigens are now recognized in most cases, and are generally nontraditional in their widespread distribution. Sensitive and specific methods for the detection of serum autoantibodies in patients affected by AILD represent a challenge for researchers and clinicians who desire to obtain an early and certain diagnosis as well as markers of disease control. To this regard, the use and interpretation of serum autoantibodies in AILD may be seen as paradigmatic for the large gaps in our knowledge based on the lack of true population-based studies. The present review article will critically discuss the available evidence on the use of autoantibody findings in the diagnosis or management of autoimmune liver disease.",
keywords = "autoimmune hepatitis, diagnosis, pathogenesis, primary biliary cirrhosis, primary sclerosing cholangitis",
author = "Achenza, {Maria Is} and Francesca Meda and Enrico Brunetta and Carlo Selmi",
year = "2012",
month = "12",
doi = "10.1586/egh.12.58",
language = "English (US)",
volume = "6",
pages = "717--729",
journal = "Expert Review of Gastroenterology and Hepatology",
issn = "1747-4124",
publisher = "Expert Reviews Ltd.",
number = "6",

}

TY - JOUR

T1 - Serum autoantibodies for the diagnosis and management of autoimmune liver diseases

AU - Achenza, Maria Is

AU - Meda, Francesca

AU - Brunetta, Enrico

AU - Selmi, Carlo

PY - 2012/12

Y1 - 2012/12

N2 - The spectrum of autoimmune liver diseases (AILD) includes primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis. The immunological mechanisms triggering the initiation and perpetuation of AILD remains unknown, while autoantigens are now recognized in most cases, and are generally nontraditional in their widespread distribution. Sensitive and specific methods for the detection of serum autoantibodies in patients affected by AILD represent a challenge for researchers and clinicians who desire to obtain an early and certain diagnosis as well as markers of disease control. To this regard, the use and interpretation of serum autoantibodies in AILD may be seen as paradigmatic for the large gaps in our knowledge based on the lack of true population-based studies. The present review article will critically discuss the available evidence on the use of autoantibody findings in the diagnosis or management of autoimmune liver disease.

AB - The spectrum of autoimmune liver diseases (AILD) includes primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis. The immunological mechanisms triggering the initiation and perpetuation of AILD remains unknown, while autoantigens are now recognized in most cases, and are generally nontraditional in their widespread distribution. Sensitive and specific methods for the detection of serum autoantibodies in patients affected by AILD represent a challenge for researchers and clinicians who desire to obtain an early and certain diagnosis as well as markers of disease control. To this regard, the use and interpretation of serum autoantibodies in AILD may be seen as paradigmatic for the large gaps in our knowledge based on the lack of true population-based studies. The present review article will critically discuss the available evidence on the use of autoantibody findings in the diagnosis or management of autoimmune liver disease.

KW - autoimmune hepatitis

KW - diagnosis

KW - pathogenesis

KW - primary biliary cirrhosis

KW - primary sclerosing cholangitis

UR - http://www.scopus.com/inward/record.url?scp=84871027098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871027098&partnerID=8YFLogxK

U2 - 10.1586/egh.12.58

DO - 10.1586/egh.12.58

M3 - Article

C2 - 23237257

AN - SCOPUS:84871027098

VL - 6

SP - 717

EP - 729

JO - Expert Review of Gastroenterology and Hepatology

JF - Expert Review of Gastroenterology and Hepatology

SN - 1747-4124

IS - 6

ER -